NanoVision’s research and development efforts focus on the application of nanotechnologies in ophthalmology to help patient compliance to drug therapies and to remove toxicity issues associated with medical treatments.

This includes:

  • Drugs delivery systems such as the Polyvinyl Alcohol Matrix (PALM) NanoGEL sustained drug delivery platform
  • New material development programs in partnership with Contamac Ltd., UK
  • Cutting-edge design technology
  • Patient adherence systems